Literature DB >> 22804624

Mesenchymal stromal cells: a key player in 'innate tolerance'?

Francesco Dazzi1, Luciene Lopes, Ling Weng.   

Abstract

The existence of a mesenchymal stromal cell (MSC) population with the main property of physically supporting parenchymal tissues has long been recognized in virtually all organs. However, it was only recently that MSC have been identified as playing a novel role in modulating inflammation. It has been extensively documented that, under particular circumstances, MSC potently impair virtually all cells of the immune system, including antigen-presenting-cells.
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh：

Year:  2012        PMID： 22804624      PMCID： PMC3482678          DOI： 10.1111/j.1365-2567.2012.03621.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  83 in total

1.  Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.

Authors:  Margaret E Groh; Basabi Maitra; Emese Szekely; Omer N Koç
Journal:  Exp Hematol       Date:  2005-08       Impact factor: 3.084

2.  Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-beta.

Authors:  Qing-Fei Kong; Bo Sun; Sha-Sha Bai; Dong-Xu Zhai; Guang-You Wang; Yu-Mei Liu; Shu-Juan Zhang; Rui Li; Wei Zhao; Yan-Yan Sun; Na Li; Qi Wang; Hai-Sheng Peng; Lian-Hong Jin; Hu-Lun Li
Journal:  J Neuroimmunol       Date:  2009-01-26       Impact factor: 3.478

Review 3.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

4.  The adaptive function of masturbation in a promiscuous African ground squirrel.

Authors:  Jane M Waterman
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

5.  Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile.

Authors:  Julian Maggini; Gerardo Mirkin; Ianina Bognanni; Josefina Holmberg; Isabel M Piazzón; Irene Nepomnaschy; Héctor Costa; Cristian Cañones; Silvina Raiden; Mónica Vermeulen; Jorge R Geffner
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

6.  Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.

Authors:  Francesco Liotta; Roberta Angeli; Lorenzo Cosmi; Lucia Filì; Cinzia Manuelli; Francesca Frosali; Benedetta Mazzinghi; Laura Maggi; Annalisa Pasini; Veronica Lisi; Veronica Santarlasci; Lara Consoloni; Maria Lucia Angelotti; Paola Romagnani; Paola Parronchi; Mauro Krampera; Enrico Maggi; Sergio Romagnani; Francesco Annunziato
Journal:  Stem Cells       Date:  2007-10-25       Impact factor: 6.277

7.  IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.

Authors:  David Polchert; Justin Sobinsky; Gw Douglas; Martha Kidd; Ada Moadsiri; Eduardo Reina; Kristyn Genrich; Swati Mehrotra; Suman Setty; Brett Smith; Amelia Bartholomew
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

8.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.

Authors:  Guangwen Ren; Liying Zhang; Xin Zhao; Guangwu Xu; Yingyu Zhang; Arthur I Roberts; Robert Chunhua Zhao; Yufang Shi
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

9.  Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo.

Authors:  Daan van Poll; Biju Parekkadan; Cheul H Cho; François Berthiaume; Yaakov Nahmias; Arno W Tilles; Martin L Yarmush
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

10.  Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure.

Authors:  Biju Parekkadan; Daan van Poll; Kazuhiro Suganuma; Edward A Carter; François Berthiaume; Arno W Tilles; Martin L Yarmush
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240
View more
  34 in total

1.  Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.

Authors:  Daan R M G Ophelders; Tim G A M Wolfs; Reint K Jellema; Alex Zwanenburg; Peter Andriessen; Tammo Delhaas; Anna-Kristin Ludwig; Stefan Radtke; Vera Peters; Leon Janssen; Bernd Giebel; Boris W Kramer
Journal:  Stem Cells Transl Med       Date:  2016-05-09       Impact factor: 6.940

Review 2.  Current Advancements and Strategies in Tissue Engineering for Wound Healing: A Comprehensive Review.

Authors:  Jasmine Ho; Claire Walsh; Dominic Yue; Alan Dardik; Umber Cheema
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-06-01       Impact factor: 4.730

Review 3.  Mesenchymal stem cells as a potent cell source for articular cartilage regeneration.

Authors:  Mohamadreza Baghaban Eslaminejad; Elham Malakooty Poor
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

4.  Mesenchymal stromal cells attenuate multiple sclerosis via IDO-dependent increasing the suppressive proportion of CD5+ IL-10+ B cells.

Authors:  Huijuan Li; Yinan Deng; Jinliang Liang; Feng Huang; Wei Qiu; Min Zhang; Youming Long; Xueqiang Hu; Zhengqi Lu; Wei Liu; Song Guo Zheng
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 5.  State-of-the-art acute and chronic GVHD treatment.

Authors:  Muhammad Omer Jamil; Shin Mineishi
Journal:  Int J Hematol       Date:  2015-04-12       Impact factor: 2.490

Review 6.  Treatment and management of graft-versus-host disease: improving response and survival.

Authors:  Catherine Garnett; Jane F Apperley; Jiří Pavlů
Journal:  Ther Adv Hematol       Date:  2013-12

7.  HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.

Authors:  Reza Abdi; Robert Moore; Shinobu Sakai; Conor B Donnelly; Marwan Mounayar; Robert Sackstein
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

Review 8.  Therapy with stem cells in inflammatory bowel disease.

Authors:  María Del Pilar Martínez-Montiel; Gonzalo Jesús Gómez-Gómez; Ana Isabel Flores
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

9.  On the origin and destination of cancer stem cells: a conceptual evaluation.

Authors:  Anja van de Stolpe
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

10.  Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.

Authors:  Y Peng; X Chen; Q Liu; X Zhang; K Huang; L Liu; H Li; M Zhou; F Huang; Z Fan; J Sun; Q Liu; M Ke; X Li; Q Zhang; A P Xiang
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.